That is, for each participant, GSH levels were estimated after correcting for partial volume effects in each voxel using the method proposed in Gasparovic et al(Gasparovic et al., 2018), and GABA levels were alpha-corrected(Harris et al., 2015), since metabolite levels are reported to differ between brain gray and white matter(Gong et al., 2022)
Semaglutide and NT-proBNP in obesity-related HFpEF
Glucagon-like peptide-1 (GLP-1) agonists, originally developed to manage type 2 diabetes, are now used to treat obesity due to their metabolic effects (6)
While its FDA-approved uses are expanding, Wegovy is not approved to treat prediabetes
Weight loss continued at the 36-week mark and never plateaued, which indicates that a longer trial would still see results